This Research Topic is Volume II of the article collection. The previous volume, which has attracted over 8K views and 1K downloads, can be found here: Diagnosis and Therapy Pediatric Hematological Malignancies - Recent Progress
.
In recent years, we have witnessed tremendous progress in both the diagnosis and treatment of haematological malignancies in children. The development the modern molecular methods allowed the identification of numerous unique expression profiles of haematological malignancies. Advances in understanding the molecular biology of cancer disease, genetic predispositions to haematological cancers, and the mechanism of drug resistance guide novel therapy strategies, called precision treatment.
The field of precision medicine has exploded through progress in sequencing technologies. Identifying genetic abnormalities is critical to achieving better outcomes in pediatric malignancies, but the development of drugs that block specific proteins and pathways remains challenging.
We invite submissions of both review papers and original research articles on topics covering the use of novel therapies in hematological malignancies.
Keywords:
hematological malignancies, chidlren, diagnosis, target therapy
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
This Research Topic is Volume II of the article collection. The previous volume, which has attracted over 8K views and 1K downloads, can be found here:
Diagnosis and Therapy Pediatric Hematological Malignancies - Recent Progress
.
In recent years, we have witnessed tremendous progress in both the diagnosis and treatment of haematological malignancies in children. The development the modern molecular methods allowed the identification of numerous unique expression profiles of haematological malignancies. Advances in understanding the molecular biology of cancer disease, genetic predispositions to haematological cancers, and the mechanism of drug resistance guide novel therapy strategies, called precision treatment.
The field of precision medicine has exploded through progress in sequencing technologies. Identifying genetic abnormalities is critical to achieving better outcomes in pediatric malignancies, but the development of drugs that block specific proteins and pathways remains challenging.
We invite submissions of both review papers and original research articles on topics covering the use of novel therapies in hematological malignancies.
Keywords:
hematological malignancies, chidlren, diagnosis, target therapy
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.